GENE ONLINE|News &
Opinion
Blog

Palforzia
M&A
Nestlé to Acquire Aimmune Therapeutics in a $2.6 Billion Merger Agreement
2020-09-01
M&A Peanut Allergy
Nestlé to Acquire Aimmune Therapeutics in a $2.6 Billion Merger Agreement
2020-08-31
Trials & Approvals Peanut Allergy
Aimmune’s PALFORZIA™ Scores FDA Win, Becomes the First Ever Treatment For Peanut Allergy
2020-02-01
Licensing Immunotherapy Drug
FDA’s Advisory Committee Recommends Palforzia’s approval for Peanut Allergy Treatment
2019-09-27
LATEST
ASCGT Meeting Navigates Biotech Downturn After Multi-Year Slump
2025-05-14
Seasonal Skin Irritations Rise, Driving Demand for Accessible and Easy-to-Use Treatments
2025-05-14
Tirzepatide Users See 20.2% Average Weight Loss in Obesity Management Trial
2025-05-14
iMMagine-1 Phase 2 Study Provides Data on Investigational Matter Characteristics and Behavior
2025-05-14
Novo Nordisk Partners with Septerna in $2.2 Billion Deal to Develop Oral Obesity Drugs
2025-05-14
SMA: Researchers Explore In Utero Treatment Methods to Mitigate Muscle Weakness Before Birth
2025-05-14
Emrelis Approved for Advanced NSCLC Patients with High c-Met Overexpression
2025-05-14
READ MORE
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-26
2025 Antibody Therapeutic & Frontiers in Biomedical Sciences Conference
Taipei, Taiwan
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top